4/A//SEC Filing
KUCHARCHUK ANDREW ALBERT 4/A
Accession 0001493152-19-003373
CIK 0001362703other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:50 PM ET
Size
8.3 KB
Accession
0001493152-19-003373
Insider Transaction Report
Form 4/AAmended
KUCHARCHUK ANDREW ALBERT
DirectorCFO & President
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-09+3,000,000→ 3,000,000 totalExercise: $0.01From: 2019-05-09Exp: 2028-05-09→ Common Stock (3,000,000 underlying) - Award
Employee Stock Option (right to buy)
2017-03-10+2,000,000→ 2,000,000 totalExercise: $0.25Exp: 2027-03-10→ Common Stock (2,000,000 underlying)
Footnotes (3)
- [F1]This form is being amended because the original Form 4 aggregated the two grants listed above as the same class of options, when they are actually two separate classes.
- [F2]One-third of the Stock Options vested on March 10, 2018 and March 10, 2019 and one-third will vest on March 10, 2020.
- [F3]Options issued as compensation approved by the Issuer's Board of Directors
Documents
Issuer
OncBioMune Pharmaceuticals, Inc
CIK 0001362703
Entity typeother
Related Parties
1- filerCIK 0001654127
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:50 PM ET
- Size
- 8.3 KB